Renewal Application: Critical Path Public Private Partnerships (U18) Clinical Trials Optional

As part of its Critical Path Initiative, FDA recognizes the need for collaborations established under the terms and conditions of a cooperative agreement to facilitate Critical Path Public-Private Partnerships / Consortia activities.

This includes developing innovative, collaborative projects

credit:


in research, education, and outreach for fostering medical product innovation, enabling the acceleration of medical product development, manufacturing, and translational therapeutics, and enhancing medical product safety.

Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $20,000,000


Who's Eligible


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Full Announcement

Additional Information of Eligibility:
Eligible OrganizationsThe following organization is eligible to apply:Critical Path Institute

Full Opportunity Web Address:
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-19-027.html

Contact:


Agency Email Description:
work email

Agency Email:


Date Posted:
2019-05-29

Application Due Date:


Archive Date:
2019-08-28


Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.






More Federal Domestic Assistance Programs


Paul S. Sarbanes Transit in the Parks | Interjurisdictional Fisheries Act of 1986 | John Ogonowski Farmer-to-Farmer Program | Safety Incentives to Prevent Operation of Motor Vehicles by Intoxicated Persons | Afghanistan Agricultural Extension Project (AAEP) |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders